Synthesis and antiviral activity of a series of novel N-phenylbenzamide and N-phenylacetophenone compounds as anti-HCV and anti-EV71 agents

A series of novel N-phenylbenzamide and N-phenylacetophenone compounds were synthesized and evaluated for their antiviral activity against HCV and EV71 (strain SZ-98). The biological results showed that three compounds (23, 25 and 41) exhibited considerable anti-HCV activity (IC50=0.57-7.12 μmol/L)...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhi Jiang (Author), Huiqiang Wang (Author), Yanping Li (Author), Zonggen Peng (Author), Yuhuan Li (Author), Zhuorong Li (Author)
Format: Book
Published: Elsevier, 2015-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_fb01be7dbaed414cb38f6f5bea6c99d1
042 |a dc 
100 1 0 |a Zhi Jiang  |e author 
700 1 0 |a Huiqiang Wang  |e author 
700 1 0 |a Yanping Li  |e author 
700 1 0 |a Zonggen Peng  |e author 
700 1 0 |a Yuhuan Li  |e author 
700 1 0 |a Zhuorong Li  |e author 
245 0 0 |a Synthesis and antiviral activity of a series of novel N-phenylbenzamide and N-phenylacetophenone compounds as anti-HCV and anti-EV71 agents 
260 |b Elsevier,   |c 2015-05-01T00:00:00Z. 
500 |a 2211-3835 
500 |a 2211-3843 
500 |a 10.1016/j.apsb.2015.03.013 
520 |a A series of novel N-phenylbenzamide and N-phenylacetophenone compounds were synthesized and evaluated for their antiviral activity against HCV and EV71 (strain SZ-98). The biological results showed that three compounds (23, 25 and 41) exhibited considerable anti-HCV activity (IC50=0.57-7.12 μmol/L) and several compounds (23, 28, 29, 30, 31 and 42) displayed potent activity against EV71 with the IC50 values lower than 5.00 μmol/L. The potency of compound 23 (IC50=0.57 μmol/L) was superior to that of reported compounds IMB-1f (IC50=1.90 μmol/L) and IMB-1g (IC50=1.00 μmol/L) as anti-HCV agents, and compound 29 possessed the highest anti-EV71 activity, comparable to the comparator drug pirodavir. The efficacy in vivo and antiviral mechanism of these compounds warrant further investigations. 
546 |a EN 
690 |a Synthesis 
690 |a N-phenylbenzamide 
690 |a N-phenylacetophenone 
690 |a Anti-HCV 
690 |a Anti-EV71 
690 |a Agents 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Acta Pharmaceutica Sinica B, Vol 5, Iss 3, Pp 201-209 (2015) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S221138351500057X 
787 0 |n https://doaj.org/toc/2211-3835 
787 0 |n https://doaj.org/toc/2211-3843 
856 4 1 |u https://doaj.org/article/fb01be7dbaed414cb38f6f5bea6c99d1  |z Connect to this object online.